Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. （打开新窗口）

Abdelrazik N, Fouda M

来源‎: Hematology 2007;12(6):533-41.

检索‎: PubMed 17852440

DOI码‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 （打开新窗口）

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. （打开新窗口）

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

来源‎: Cancer 2012;118(3):848-55.

检索‎: PubMed 21751205

DOI码‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 （打开新窗口）

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. （打开新窗口）

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

来源‎: Pediatr Hematol Oncol 2008;25(6):509-21.

检索‎: PubMed 18728970

DOI码‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 （打开新窗口）

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. （打开新窗口）

Durmaz O, Demirkaya M, Sevinir B

来源‎: Pediatr Hematol Oncol 2011;28(6):461-8.

检索‎: PubMed 21707225

DOI码‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 （打开新窗口）

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. （打开新窗口）

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

来源‎: J Clin Oncol 2010;28(13):2239-45.

检索‎: PubMed 20368566

DOI码‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 （打开新窗口）

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. （打开新窗口）

Hassan BA, Yusoff ZB

来源‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

检索‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 （打开新窗口）

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. （打开新窗口）

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

来源‎: Curr Med Res Opin 2009;25(9):2109-20.

检索‎: PubMed 19601709

DOI码‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 （打开新窗口）

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. （打开新窗口）

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

来源‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

检索‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 （打开新窗口）

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. （打开新窗口）

Hiradfar A, Banihosseinian M

来源‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

检索‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 （打开新窗口）

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. （打开新窗口）

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

来源‎: Pediatr Blood Cancer 2009;53(1):7-12.

检索‎: PubMed 19229970

DOI码‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 （打开新窗口）

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. （打开新窗口）

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

来源‎: Cancer 2013;119(1):107-14.

检索‎: PubMed 22744794

DOI码‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 （打开新窗口）

Erythropoietic growth factors for children with cancer: a systematic review of the literature. （打开新窗口）

Mystakidou K, Potamianou A, Tsilika E

来源‎: Curr Med Res Opin 2007;23(11):2841-7.

检索‎: PubMed 17910805

DOI码‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 （打开新窗口）

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. （打开新窗口）

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

来源‎: J Clin Oncol 2006;24(22):3583-9.

检索‎: PubMed 16877725

DOI码‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 （打开新窗口）

The role of recombinant erythropoietin in childhood cancer. （打开新窗口）

Shankar AG

来源‎: Oncologist 2008;13(2):157-66.

检索‎: PubMed 18305061

DOI码‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 （打开新窗口）

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. （打开新窗口）

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

来源‎: MEDICC Rev 2010;12(3):27-31.

检索‎: PubMed 20697335

DOI码‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 （打开新窗口）

A single institutional experience: is epoetin alpha effective in anemic children with cancer? （打开新窗口）

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

来源‎: Pediatr Hematol Oncol 2004;21(1):1-8.

检索‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 （打开新窗口）

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. （打开新窗口）

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

来源‎: Pediatr Hematol Oncol 2014;31(5):442-7.

检索‎: PubMed 24088186

DOI码‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 （打开新窗口）

Early epoetin alfa treatment in children with solid tumors. （打开新窗口）

Zoubek A, Kronberger M

来源‎: Med Pediatr Oncol 2002;39(4):459-62.

检索‎: PubMed 12203664

DOI码‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 （打开新窗口）

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. （打开新窗口）

Crary SE, Hall K, Buchanan GR.

来源‎: Pediatr Blood Cancer 2011;56(4):615-9.

检索‎: PubMed 21298748

DOI码‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 （打开新窗口）

Intravenous iron sucrose for children with iron deficiency anemia. （打开新窗口）

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

来源‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

检索‎: PubMed 28562517

DOI码‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 （打开新窗口）

Advances in Pediatric Intravenous Iron Therapy. （打开新窗口）

Mantadakis E.

来源‎: Pediatr Blood Cancer 2016;63(1):11-6.

检索‎: PubMed 26376214

DOI码‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 （打开新窗口）

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. （打开新窗口）

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

来源‎: Cochrane Database Syst Rev 2016;(2):CD009624.

检索‎: PubMed 26845108

DOI码‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 （打开新窗口）

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. （打开新窗口）

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

来源‎: J Clin Oncol 2008;26(10):1619-25.

检索‎: PubMed 18375891

DOI码‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 （打开新窗口）

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. （打开新窗口）

Plummer ES, Crary SE, McCavit TL, Buchanan GR

来源‎: Pediatr Blood Cancer 2013;60(11):1747-52.

检索‎: PubMed 23832487

DOI码‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 （打开新窗口）